Lupin Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review
- June 9, 2026
- Posted by: Kunal Singla
- Category: News
Lupin CMP: Rs 2,254 (2026). 52W High: Rs 2,494. 52W Low: Rs 1,837. Mkt Cap: Rs 103,106 Cr. P/E: 17.1. Analyst Consensus Target: Rs 2,550.
The Lupin stock prediction for 2026 from leading brokerages and research analysts covers a wide range that reflects the company’s sector dynamics, earnings trajectory and macro environment. The Lupin stock prediction published in this article is sourced from publicly available research and may or may not be achieved. Investors should treat any Lupin share price prediction as one data point and not as a guarantee of future performance.
Interest in the Lupin stock forecast for 2026 has grown as investors look for anchor points in a volatile market. This article reviews every dimension of the Lupin stock prediction that analysts are tracking, including key business drivers, bull and bear scenarios and the primary risks that could shift the Lupin share price prediction in either direction. The analyst consensus for 2026 should be verified with the latest brokerage reports before any investment decision.
Click Here – Get Free Investment Predictions
What Analysts Predict for Lupin Stock in 2026
Analyst consensus on the Lupin stock prediction for 2026 is tracked by leading brokerages and research firms. The table below shows the latest available Lupin stock forecast data from ICICI Securities and Kotak Securities. All Lupin share price prediction figures are sourced from publicly available research and should be verified against the most current brokerage reports before publishing.
| Brokerage | Rating | Lupin Stock Prediction (Rs) | Updated |
|---|---|---|---|
| ICICI Securities | Buy | Rs 2,600 | 2026 |
| Kotak Securities | Buy | Rs 2,500 | 2026 |
| Analyst Consensus | — | Rs 2,550 | 2026 |
The Lupin stock prediction range from the analyst community reflects a genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. Each Lupin share price prediction from an individual brokerage should be read alongside the stated assumptions. The implied upside in the Lupin stock forecast from the current market price of Rs 2,254 may or may not be realised by the end of 2026.
3 Stocks Building Serious Momentum Right Now
When Univest analysts identify high-conviction stock opportunities, investors pay attention.
Our research team has now shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.
- Discover stocks investors are actively accumulating
- High-conviction opportunities backed by research
- Designed for the next phase of market growth
Unlock the latest Top Stock Picks now on Univest
Lupin Company Overview
Lupin is a significant player in India’s pharmaceutical industry with a presence across domestic formulations, US generics and specialty segments. The Lupin stock prediction for 2026 reflects both the pipeline growth potential and regulatory risk. Understanding this context is the starting point for any Lupin stock prediction and helps investors assess whether the analyst Lupin stock forecast is grounded in a realistic view of the company’s competitive position.
| Metric | Value |
|---|---|
| NSE Ticker | LUPIN |
| Sector | Pharmaceuticals and Healthcare |
| CMP | Rs 2,254 (2026) |
| 52 Week High | Rs 2,494 |
| 52 Week Low | Rs 1,837 |
| Market Cap | Rs 103,106 Cr |
| P/E Ratio | 17.1 |
| Lupin Stock Prediction Consensus (12M) | Rs 2,550 |
Lupin Stock Prediction by Time Horizon
Analysts split the Lupin share price prediction across different time frames because the variables that drive the short-term view are very different from those that shape a 3 to 5 year outlook. The following three horizons give a structured way to think about the range of analyst estimates for 2026 and beyond.
Short-Term Lupin Stock Prediction (1 to 3 Months)
The near-term analyst view on Lupin reflects current market sentiment, sector news flow and upcoming earnings data points. Analysts forming a short-term Lupin stock forecast are watching key support and resistance levels around the current market price of Rs 2,254. A Lupin share price prediction in the near term is the most uncertain of all time horizons and may or may not hold as new information emerges.
12-Month Lupin Stock Prediction
The 12 month Lupin stock prediction from leading brokerages represents the most widely cited analyst consensus for the full-year 2026 outlook. ICICI Securities has set a target of Rs 2,600 (Buy) while Kotak Securities has set a target of Rs 2,500 (Buy). Most research desks refresh their Lupin stock forecast within two to four weeks of each quarterly earnings print. The Lupin share price prediction should be verified against the most recent analyst reports before being used as an investment reference.
Long-Term Lupin Stock Prediction
The long-term Lupin stock prediction, built on a 3 to 5 year view, is based on assumptions about demand recovery, margin expansion and revenue diversification. Analysts who set a higher long-term Lupin stock forecast cite the company’s structural growth drivers in the Pharmaceuticals and Healthcare sector. The long-term Lupin share price prediction should be treated as a directional indicator and may or may not prove accurate over the forecast period.
Lupin Stock Forecast: Key Factors Behind the Prediction
Understanding what drives the Lupin stock forecast requires reviewing the variables that most analysts reference when forming their Lupin share price prediction for 2026. The following four factors appear consistently in research reports on the Lupin stock prediction and are the primary inputs into the bull and bear case scenarios.
US Generic Revenue
US generics revenue is the most watched metric in the Lupin stock forecast. USFDA approval timelines and price erosion rates directly affect the Lupin share price prediction from most research desks.
Domestic Formulations Growth
Domestic formulation growth provides a stable base that supports the Lupin stock prediction even when export growth faces headwinds.
R&D Pipeline
The depth and commercialization pace of the R&D pipeline is a key variable in the long-term Lupin share price prediction. New product approvals are cited as catalysts for the Lupin stock prediction.
EBITDA Margin
Sustained EBITDA margin expansion is typically the basis for the bullish Lupin stock forecast. Margin recovery strengthens the Lupin share price prediction from most research desks.
Lupin Stock Prediction: Bull and Bear Scenarios
Any complete Lupin share price prediction must account for both positive and negative outcomes. The following scenarios are built from analyst commentary and sector data, representing the range of the Lupin stock prediction rather than a fresh estimate from Univest.
| Scenario | Lupin Stock Prediction | Key Conditions |
|---|---|---|
| Bull Case | Rs 2,600 | Strong business execution, margin improvement, favourable macro environment and sector re-rating |
| Base Case | Rs 2,550 | Steady performance, gradual recovery, margins hold, growth on track |
| Bear Case | Rs 1837 | Demand deterioration, margin pressure, sector de-rating and macro headwinds |
The bull case Lupin stock forecast assumes most positive variables converge simultaneously. The bear case Lupin share price prediction reflects a scenario where demand deteriorates and the sector de-rates below current multiples. The base case Lupin stock prediction represents the analyst consensus view of Rs 2,550, which may or may not prove accurate.
How Analysts Are Reading the Lupin Stock Story
Analyst reviews of the Lupin share price prediction consistently highlight two opposing forces in 2026. The positive case for the Lupin stock forecast rests on the company’s core business strengths in the Pharmaceuticals and Healthcare sector, including competitive position and potential for margin or volume improvement over the next four quarters.
The cautious side of the analyst view points to near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Analysts who maintain a conservative Lupin stock prediction cite these as the primary reasons for staying neutral or cautious on the stock. Many research desks have revised their view since the start of 2026 as macro data evolved.
Overall, the Lupin stock prediction consensus from the analyst community is built on real business strengths set against real risks. Investors should read the full Lupin stock forecast report from each brokerage, including assumptions and risk disclosures, before using any Lupin share price prediction as an investment reference.
Key Risks That Could Change the Lupin Stock Prediction
Any Lupin share price prediction carries risks that could shift the Lupin stock forecast materially in either direction. Investors should review these risks before acting on any Lupin stock prediction from an analyst or research desk.
USFDA Regulatory Risk
Import alerts and warning letters from the USFDA are the most significant risks to the Lupin stock prediction. A facility closure would force an immediate sharp revision to the Lupin share price prediction.
Price Erosion in the US
Pricing pressure in US generics compresses the revenue per product and affects the Lupin stock forecast. Aggressive price erosion pushes the Lupin share price prediction toward the bear case.
R&D Execution Risk
Delays in clinical trials or approval failures affect the Lupin stock prediction. The Lupin share price prediction is particularly sensitive to key pipeline asset announcements.
Currency Risk
A strengthening rupee against the dollar reduces export realisation and affects the Lupin stock forecast. Currency risk is embedded in conservative Lupin share price prediction models.
How to Monitor the Lupin Stock Forecast and Make Decisions
Check Live Lupin Fundamentals on the Univest Screener
Start by opening a demat account with a SEBI registered broker if you do not already have one. Before acting on any Lupin share price prediction, ensure you understand the risks involved in equity investing.
Track the Lupin stock prediction consensus quarterly: after every earnings release, most brokerages revise their Lupin stock forecast within two weeks. Comparing the revised Lupin stock prediction to the previous estimate tells you whether analyst sentiment on the stock is improving or deteriorating.
Compare the current market price of Rs 2,254 with the analyst target range of Rs 2,600 to Rs 2,500. The Lupin share price prediction band can be wide, so position size should reflect that uncertainty.
Review the Lupin stock prediction every quarter against the key business metrics for the Pharmaceuticals and Healthcare sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many.
Download the Univest iOS App or Univest Android App to track the live Lupin stock prediction and Lupin share price prediction changes in real time.
Conclusion
The Lupin stock prediction for 2026 reflects the analyst community’s assessment of Lupin’s competitive position, earnings trajectory and macro environment. ICICI Securities sets a Buy target of Rs 2,600 while Kotak Securities has a Buy target of Rs 2,500, giving an analyst consensus of Rs 2,550. The Lupin stock forecast is set against near-term risks that make the Lupin share price prediction range wide. Any estimate should be verified with the latest brokerage reports and does not constitute investment advice from Univest.
The analyst forecast will be revised after every quarterly result. Track the latest Lupin stock prediction and Lupin share price prediction changes on the Univest Screener and app to stay updated as 2026 progresses.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Disclaimer: Data and figures in this article are sourced from publicly available information on Google and other public platforms. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Lupin Stock Prediction 2026
What is the Lupin stock prediction for 2026?
Ans. The Lupin stock prediction for 2026 is based on analyst consensus from leading brokerages including ICICI Securities and Kotak Securities. The Lupin share price prediction range reflects the company’s fundamentals, sector outlook and macro environment. All estimates are analyst views and may or may not be achieved.
Is the Lupin stock prediction bullish or bearish?
Ans. The Lupin stock prediction for 2026 is divided, with ICICI Securities maintaining a Buy stance with a target of Rs 2,600. The Lupin stock forecast consensus points to potential movement from current levels, though the Lupin share price prediction range is wide, reflecting macro uncertainty.
What is the Lupin share price prediction based on fundamentals?
Ans. The Lupin share price prediction built on fundamentals considers the US generic pipeline, domestic growth, EBITDA margin and regulatory compliance track record. Analysts tracking the Lupin stock forecast closely cite these variables as the primary drivers of the 2026 outlook. Each analyst estimate may or may not reflect actual future performance.
What is the long-term Lupin stock prediction?
Ans. The long-term Lupin stock prediction is built around the assumption that the company’s core business drivers sustain over a multi-year horizon. Analysts with a higher Lupin stock forecast point to demand recovery, margin improvement and revenue diversification. The long-term estimate carries more uncertainty than the 12-month consensus of Rs 2,550.
What are the key risks to the Lupin stock prediction?
Ans. The key risks to the Lupin stock prediction in 2026 include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Analysts who set a lower Lupin share price prediction cite these as the primary downside risks. Every estimate should be read alongside its stated risk assumptions.
What does the Lupin stock forecast say for 2026?
Ans. The Lupin stock forecast for 2026 reflects a cautiously positive analyst consensus based on the company’s fundamental strengths. ICICI Securities has a Buy rating with a target of Rs 2,600 while Kotak Securities has a Buy rating with a target of Rs 2,500. These Lupin share price prediction estimates may or may not prove accurate.
Where can I track the latest Lupin stock prediction?
Ans. You can track the latest Lupin stock prediction, live price and fundamentals on the official NSE and BSE websites and on the Univest app and screener, alongside every updated Lupin share price prediction and stock forecast from the analyst community.
